Condition: Alcohol Use Disorder · Alcohol-related Liver Disease · Sponsor: University of Wisconsin, Madison
This protocol describes a randomized controlled trial testing the effectiveness and implementability of the CHESS Health Connections smartphone application among patients with alcohol-associated liver disease (ALD) at two medical centers in Michigan and Wisconsin, in two types of clinics: general hepatology and multidisciplinary that offers care for advanced ALD alongside co-located, integrated mental health and substance abuse treatment. The long-term goal of this and future work is to prevent disease progression and promote healthy behaviors by improving the rate of abstinence among patients with ALD earlier in the course of their disease. 298 participants will be enrolled and can expect to be on study for up to 6 months.
This description comes directly from the study's public registry record.
Jared P McDonald, MBA · 608-263-4022 · jared.mcdonald@fammed.wisc.edu
Always discuss trial participation with your own doctor first.
| Henry Ford + Michigan State University Health Center | Lansing, Michigan, United States | Recruiting |
| UW General Hepatology Clinic | Madison, Wisconsin, United States | Recruiting |
| UW Multidisciplinary ALD Clinic | Madison, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06305624